Systemic markers of oxidative status and colorectal adenomatous polyps

Annals of Epidemiology

Volumn 22, Issue 8, 2012, Pages 587-591

  Siamakpour Reihani, Sharareh ^a   Scarbrough, Peter M ^a   Wang, Frances ^a   Spasojevic, Ivan ^a   Base, Karel ^a   Sedjo, Rebecca ^b   D'Agostino, Ralph B ^c   Il'yasova, Dora ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Global Health and Health Disparities   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoma; Adenomatous polyps; Biomarkers; Colorectal cancer; Epidemiology; F2 Isoprostanes; Oxidative stress

Indexed keywords

2,3 DINOR ISOPROSTANE 2ALPHA 3; 8,12 ISO ISOPROSTANE 2ALPHA 6; ISOPROSTANE 2ALPHA 3; ISOPROSTANE 2ALPHA 6; ISOPROSTANE DERIVATIVE; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; COLORECTAL CANCER; COLORECTAL POLYP; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPOTHESIS; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; TANDEM MASS SPECTROMETRY; URINALYSIS;

ADENOMATOUS POLYPS; ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; COMORBIDITY; F2-ISOPROSTANES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OVERWEIGHT; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; PREVALENCE; SMOKING; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 84863844027     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.05.001     Document Type: Article

References (35)

1. Mena S., Ortega A., Estrela J.M. Oxidative stress in environmental-induced carcinogenesis. Mutat Res 2009, 674. 36-4.
2. Thaiparambil J.T., Vadhanam M.V., Srinivasan C., Gairola C.G., Gupta R.C. Time-dependent formation of 8-oxo-deoxyguanosine in the lungs of mice exposed to cigarette smoke. Chem Res Toxicol 2007, 20:1737-1740.
3. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 2004, 142:231-255.
4. Takahashi K., Equchi H., Arihiro K., Ito R., Koyama K., Soda M., et al. The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose. Mol Carcinog 2007, 46:242-248.
5. Lock K., Pomerleau J., Causer L., Altmann D.R., McKee M. The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bull World Health Organ 2005, 83:100-108.
6. Wu X., Cai H., Xiang Y.B., Cai Q., Yang G., Liu D., et al. Intra-person variation of urinary biomarkers of oxidative stress and inflammation. Cancer Epidemiol Biomarkers Prev 2010, 19:947-952.
7. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., et al. Oxidants in mitochondria: from physiology to diseases. Biochem Biophys Acta 1995, 1271:67-74.
8. Epplein M., Franke A.A., Cooney R.V., Morris J.S., Wilkens L.R., Goodman M.T., et al. Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009, 18:1962-1970.
9. Gill J.K., Franke A.A., Steven Morris J., Cooney R.V., Wilkens L.R., Le Marchand L., et al. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control 2009, 20:1161-1171.
10. Dai Q., Gao Y.T., Shu X.O., Yang G., Milne G., Cai Q., et al. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study. J Clin Oncol 2009, 27:2482-2488.
11. Fam S.S., Morrow J.D. The isorpostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem 2003, 10:1723-1740.
12. Preston D.L., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M., et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007, 168:1-64.
13. Fedirko V., Tramacere I., Bagnardi V., Rota M., Scotti L., Islami F., et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011, 22:1952-1972.
14. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
15. Kolligs F.T., Crispin A., Munte A., Wagner A., Mansmann U., Goke B. Risk of advanced colorectal neoplasia according to age and gender. PLoS One 2011, 6:e20076.
16. Gellad Z.F., Weiss D.G., Ahnen D.J., Lieberman D.A., Jackson G.L., Provensale D. Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380. Am J Gastroenterol 2010, 105:1746-1752.
17. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977-1981.
18. Tiemersma E.W., Wark P.A., Ocké M.C., Bunschoten A., Otten M.H., Kok F.J., et al. Alcohol consumption, alcohol dehydrogenase 3 polymorphism, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003, 12:419-425.
19. Martinez M.E., McPherson R.S., Annegers J.F., Levin B. Cigarette smoking and alcohol consumption as risk factors for colorectal adenomatous polyps. J Natl Cancer Inst 1995, 87:274-279.
20. Shin A., Hong C.W., Sohn D.K., Chang Kim B., Han K.S., Chang H.J., et al. Associations of cigarette smoking and alcohol consumption with advanced or multiple colorectal adenoma risks: a colonoscopy-based case-control study in Korea. Am J Epidemiol 2011, 174:552-562.
21. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 1990, 87:9383-9387.
22. Roberts L.J., Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000, 28:505-513.
23. Zhang H., Il'yasova D., Sztaray J., Young S.P., Wang F., Millington D.S. Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alphpa) in human urine using liquid chromatography-tandem mass spectrometry. Anal Biochem 2010, 399:302-304.
24. Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal 2008, 10:1405-1434.
25. Yan W., Byrd G.D., Ogden M.W. Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J Lipid Res 2007, 48:1607-1617.
26. Dorjgochoo T., Gao Y.T., Chow W.H., Shu X.O., Yang G., Cai Q., et al. Obesity, age, and oxidative stress in middle-aged and older women. Antioxid Redox Signal 2011, 14:2453-2460.
27. Il'yasova D., Wang F., Spasojevic I., Base K., D'Agostino R.B., Wagenknecht L.E. Urinary f(2)-isoprostanes, obesity, and weight gain in the IRAS cohort. Obesity (Silver Spring) 2011 Sep 29, [Epub ahead of print].
28. Wagenknecht L.E., Mayer E.J., Rewers M., Haffner S., Selby J., Borok G.M., et al. The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 1995, 5:464-472.
29. Sedjo R.L., Byers T., Levin T.R., Haffner S.M., Saad M.F., Tooze J.A., et al. Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2007, 16:526-531.
30. Il'yasova D., Spasojevic I., Wang F., Tolun A.A., Base K., Young S.P., et al. Urinary biomarkers of oxidative status in a clinical model of oxidative assault. Cancer Epidemiol Biomarkers Prev 2010, 19:1506-1510.
31. Block G., Hartman A.M., Dresser C.M., Carroll M.D., Gannon J., Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986, 124:453-469.
32. Block G., Woods M., Potosky A., Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990, 43:1327-1335.
33. Morimoto L.M., Newcomb P.A., Ulrich C.M., Bostick R.M., Lais C.J., Potter J.D. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?. Cancer Epidemiol Biomarkers Prev 2002, 11:1012-1018.
34. Reid M.E., Marshall J.R., Roe D., Lebowitz M., Alberts D., Mattacharyya A.K., et al. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003, 12:1006-1011.
35. Lee G.E., Park H.S., Yun K.E., Jun S.H., Kim H.K., Cho S.I., et al. Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity (Silver Spring) 2008, 16:1343-1439.